This bill amends Section 37-2711 of the Idaho Code to classify the drugs Mifepristone and Misoprostol as Schedule IV controlled substances. The inclusion of these drugs in Schedule IV indicates that they are recognized as having a lower potential for abuse compared to substances in higher schedules, while still being regulated due to their medical use. The bill also removes Pentazocine from the list of substances in this section, indicating a shift in the regulatory focus.

Additionally, the bill declares an emergency, which allows it to take effect on July 1, 2025. This expedited timeline suggests a sense of urgency regarding the regulation of Mifepristone and Misoprostol, likely in response to ongoing discussions about their use and availability in medical settings.

Statutes affected:
Bill Text: 37-2711